SAMI ALI: Open Payments
NPI 1306491121 · CLAREMONT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 22 payments from 9 companies in 2025. Trend: 2023 $887 · 2024 $544 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $226 |
| GENZYME CORPORATION | 6 | $165 |
| Stryker Corporation | 1 | $108 |
| GlaxoSmithKline, LLC. | 3 | $87 |
| Optinose US, Inc. | 2 | $42 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Lilly USA, LLC | 1 | $23 |
| Ethicon US, LLC | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $18 |
Products named: DUPIXENT, CLARIFIX, NUCALA, Xhance, INSPIRE, ZEPBOUND, SURGICEL NU-KNIT, Ryaltris.
Industry payments across CA — which companies pay providers there.
